Replaced Notes. If a Note is replaced pursuant to Section 2.13, then such Note will cease to be outstanding at the time of its replacement, unless the Trustee and the Company receive proof reasonably satisfactory to them that such Note is held by a “bona fide purchaser” under applicable law.
Appears in 135 contracts
Samples: Indenture (Ugi Corp /Pa/), Indenture (Haemonetics Corp), Indenture (Peloton Interactive, Inc.)
Replaced Notes. If a Note is replaced pursuant to Section 2.132.12, then such Note will cease to be outstanding at the time of its replacement, unless the Trustee and the Company receive proof reasonably satisfactory to them that such Note is held by a “bona fide purchaser” under applicable law.
Appears in 29 contracts
Samples: Indenture (Rexford Industrial Realty, Inc.), Indenture (Rexford Industrial Realty, Inc.), Conversion Notice (Rocket Lab USA, Inc.)
Replaced Notes. If a Note is replaced pursuant to Section 2.133.07, then such Note will cease to be outstanding at the time of its replacement, unless the Trustee and the Company receive receives proof reasonably satisfactory to them it that such Note is held by a “bona fide purchaser” purchaser under applicable law.
Appears in 4 contracts
Samples: Securities Purchase Agreement (Graf Acquisition Corp. IV), Senior Convertible Note Purchase Agreement (Scynexis Inc), Senior Convertible Note Purchase Agreement (Scynexis Inc)
Replaced Notes. If a Note is replaced pursuant to Section 2.132.8 of the Base Indenture, then such Note will cease to be outstanding at the time of its replacement, unless the Trustee and the Company receive proof reasonably satisfactory to them that such Note is held by a “bona fide purchaser” under applicable law.
Appears in 3 contracts
Samples: First Supplemental Indenture (Mesa Laboratories Inc /Co), Verastem, Inc., Verastem, Inc.
Replaced Notes. If a Note is replaced pursuant to Section 2.132.07 of the Base Indenture, then such Note will cease to be outstanding at the time of its replacement, unless the Trustee and the Company receive proof reasonably satisfactory to them that such Note is held by a “bona fide purchaser” under applicable law.
Appears in 2 contracts
Samples: Cytokinetics, Incorporated (Cytokinetics Inc), Indenture (Retrophin, Inc.)
Replaced Notes. If a Note is replaced pursuant to Section 2.13, then such Note will cease to be outstanding at the time of its replacement, unless the Trustee and the Company receive proof reasonably satisfactory to them that such Note is held by a “bona fide purchaser” under applicable law.. (C)
Appears in 2 contracts
Replaced Notes. If a Note is replaced pursuant to Section 2.132.07 of the Base Indenture, then such Note will cease to be outstanding Outstanding at the time of its replacement, unless the Trustee and the Company receive proof reasonably satisfactory to them that such Note is held by a “bona fide purchaser” under applicable law.
Appears in 2 contracts
Samples: First Supplemental Indenture (Inseego Corp.), Tilray Brands, Inc.
Replaced Notes. If a Note is replaced pursuant to Section 2.13, then such Note will cease to be outstanding at the time of its replacement, unless the Trustee and the Company receive proof reasonably satisfactory to them that such Note is held by a “bona fide protected purchaser” under applicable law.
Appears in 2 contracts
Samples: Supplemental Indenture (Maxeon Rooster HoldCo, Ltd.), Indenture (Sunpower Corp)
Replaced Notes. If a Note is replaced pursuant to Section 2.132.12, then such Note will cease to be outstanding at the time of its replacement, unless the Trustee and the Company receive proof reasonably satisfactory to them that such Note is held by a “bona fide purchaser” under applicable law.. (C)
Appears in 1 contract
Samples: Xeris Biopharma Holdings, Inc.
Replaced Notes. If a Note is replaced pursuant to Section 2.132.16, then such Note will cease to be outstanding at the time of its replacement, unless the Trustee and the Company receive proof reasonably satisfactory to them that such Note is held by a “bona fide purchaser” under applicable law.
Appears in 1 contract
Samples: Indenture (Verastem, Inc.)
Replaced Notes. If a Note is replaced pursuant to Section 2.133.06(a), then such Note will cease to be outstanding at the time of its replacement, unless the Trustee and the Company receive receives proof reasonably satisfactory to them it that such Note is held by a “bona fide purchaser” purchaser under applicable law.
Appears in 1 contract
Samples: Senior Convertible Note Purchase Agreement (Scynexis Inc)
Replaced Notes. If a Note is replaced pursuant to Section 2.13, then such Note will cease to be outstanding at the time of its replacement, unless the Trustee and the Company receive proof reasonably satisfactory to them that such Note is held by a “bona fide purchaser” under applicable law.. Exhibit 4.1
Appears in 1 contract
Samples: Indenture (Cardlytics, Inc.)
Replaced Notes. If a Note is replaced pursuant to Section 2.13Section 2.12, then such Note will cease to be outstanding at the time of its replacement, unless the Trustee and the Company receive proof reasonably satisfactory to them that such Note is held by a “bona fide purchaser” under applicable law.
Appears in 1 contract
Samples: Indenture (Lucid Group, Inc.)
Replaced Notes. If a Note is replaced pursuant to Section 2.133.6 of the Base Indenture, then such Note will cease to be outstanding at the time of its replacement, unless the Trustee and the Company receive proof reasonably satisfactory to them that such Note is held by a “bona fide purchaser” under applicable law.
Appears in 1 contract
Replaced Notes. If a Note is replaced pursuant to Section Section 2.13, then such Note will cease to be outstanding at the time of its replacement, unless the Trustee and the Company receive proof reasonably satisfactory to them that such Note is held by a “bona fide purchaser” under applicable law.
Appears in 1 contract
